{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:30:47Z","timestamp":1772749847355,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T00:00:00Z","timestamp":1205280000000},"content-version":"vor","delay-in-days":9842,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1981,4]]},"abstract":"<jats:p><jats:bold>S<jats:sc>ummary<\/jats:sc>. <\/jats:bold> The proportion of T\u03b3 and T\u03bc lymphocytes was studied in 40 cases of B\u2010chronic lymphocytic leukaemia (B\u2010CLL) and six of B\u2010prolymphocytic leukaemia (B\u2010PLL). The significant increase in Ty cells, previously reported in two small B\u2010CLL series, was confirmed and shown to be directly correlated with the clinical stages of the disease (P &lt; 0.01 to &lt; 0.001). The normal T\u03bc: T\u03b3 ratio (2.3:1) was reversed in B\u2010CLL (1:1.4) and B\u2010PLL (1:1.9). The proportion of T\u03bc cells was decreased but was not related to stage.<\/jats:p><jats:p>Our findings suggest that the increase in Ty cells may be responsible for the hypogammaglobulinaemia of B\u2010CLL. This is supported by two sets of observations. First, serum Ig levels were more often normal in cases in Stages 0 and 1 than in Stages II\u2010IV (P &lt; 0.05), while the levels of two or three Ig classes were below normal in Stages II\u2010IV twice as frequently. Secondly, splenic irradiation in one case was followed by a fall in the absolute number of Ty lymphocytes, a reversion to normal of the T\u03bcW: T\u03b3 ratio and an improvement in serum Ig levels. Thus, the imbalance in the regulatory T\u2010cell subsets may provide an important clue to understand the pathogenic mechanism of the immunodeficiency in the chronic B\u2010cell leukaemias.<\/jats:p>","DOI":"10.1111\/j.1365-2141.1981.tb02682.x","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T16:29:11Z","timestamp":1205339351000},"page":"539-544","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Increase in Ty Lymphocytes in B\u2010Cell Chronic Lymphocytic Leukaemia"],"prefix":"10.1111","volume":"47","author":[{"given":"D.","family":"Catovsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela","family":"Matutes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Foa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A. G.","family":"Galton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,12]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-197907000-00001"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jnci\/61.1.5","article-title":"Suppressor cells in neoplastic disease","volume":"61","author":"Broder S.","year":"1978","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_2_1_4_1","first-page":"811","volume-title":"Differentiation of Normal and Neoplastic Hentatopoietic Cells","author":"Catovsky D.","year":"1978"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.122.3.1087","article-title":"T\u2010cell helper defect in patients with chronic lymphocytic leukemia","volume":"122","author":"Chiorazzi N.","year":"1979","journal-title":"Journal of Immunology"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197908)44:2<483::AID-CNCR2820440217>3.0.CO;2-Z"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(78)90270-8"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0308-2261(21)00560-9","article-title":"Radiotherapy as primary treatment for chronic lymphocytic leukaemia","volume":"6","author":"Johnson R.E.","year":"1977","journal-title":"Clinics in Haematology"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood.V54.2.540.540","article-title":"T\u2010cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribution and in vitro receptor maturation","volume":"54","author":"Kay N.E.","year":"1979","journal-title":"Blood"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1980.tb02366.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830050812"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1979.tb00277.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.151.4.969"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.118.2.642","article-title":"Enhancement by irradiated T\u2010cells of human plasma cell production; dissection of helper and suppressor functions in vitro","volume":"118","author":"Siegal F.P.","year":"1977","journal-title":"Journal of Immunology"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-88-2-226"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.1981.tb02682.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.1981.tb02682.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T10:16:47Z","timestamp":1699697807000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.1981.tb02682.x"}},"subtitle":["II. CORRELATION WITH CLINICAL STAGE AND FINDINGS IN B\u2010PROLYMPHOCYTIC LEUKAEMIA"],"short-title":[],"issued":{"date-parts":[[1981,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1981,4]]}},"alternative-id":["10.1111\/j.1365-2141.1981.tb02682.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.1981.tb02682.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,4]]},"assertion":[{"value":"2008-03-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}